2.31
price up icon3.12%   0.07
after-market Handel nachbörslich: 2.30 -0.01 -0.43%
loading
Schlusskurs vom Vortag:
$2.24
Offen:
$2.27
24-Stunden-Volumen:
53,511
Relative Volume:
0.53
Marktkapitalisierung:
$5.86M
Einnahmen:
$102.80K
Nettoeinkommen (Verlust:
$-5.32M
KGV:
-0.6079
EPS:
-3.8
Netto-Cashflow:
$-5.45M
1W Leistung:
+1.76%
1M Leistung:
-61.44%
6M Leistung:
-23.00%
1J Leistung:
-58.20%
1-Tages-Spanne:
Value
$2.10
$2.34
1-Wochen-Bereich:
Value
$1.9516
$2.34
52-Wochen-Spanne:
Value
$1.92
$6.90

Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile

Name
Firmenname
Creative Medical Technology Holdings Inc
Name
Telefon
480-399-2822
Name
Adresse
211 E. OSBORN RD., PHOENIX
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
CELZ's Discussions on Twitter

Vergleichen Sie CELZ mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CELZ
Creative Medical Technology Holdings Inc
2.31 5.86M 102.80K -5.32M -5.45M -3.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten

pulisher
Apr 04, 2025

Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders - MSN

Apr 04, 2025
pulisher
Apr 01, 2025

Mergers & Acquisitions Tracker - Plastics News

Apr 01, 2025
pulisher
Mar 30, 2025

Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World

Mar 30, 2025
pulisher
Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Mar 26, 2025
pulisher
Mar 25, 2025

Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 21, 2025

Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

FDA approves expanded trial for back pain cell therapy - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial -March 20, 2025 at 08:27 am EDT - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times

Mar 20, 2025
pulisher
Mar 19, 2025

Nanoparticle Drug Delivery Market Growth, Generated - openPR.com

Mar 19, 2025
pulisher
Mar 18, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 18, 2025
pulisher
Mar 16, 2025

Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Apple Stock Forecast: Where Will It Be In 5 Years? - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Revolutionary: Stem Cell Therapy Puts Creative Medical on Profit Track - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Sexual Assault in South Sudan: Experts Stunned by Breakthrough Technology - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Yahoo

Mar 16, 2025
pulisher
Mar 16, 2025

When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Simply Wall St

Mar 16, 2025
pulisher
Mar 16, 2025

Delaware Court Just Changed the Game for Big Business - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Shocking: Trump Tariffs Spark Market Sell-Off - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Trump Tariffs in Chaos: Markets React - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Revolutionary: Medical Stem Cells Unlock Profit for CELZ - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Breaking: Trump Trade War Exposes Hidden Dangers - GeeksULTD

Mar 16, 2025
pulisher
Mar 14, 2025

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC 10-K Report - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Hyde Park Capital Advises Infiniti Medical on its Sale to CIMA Animal Health, a Portfolio Company of Incline Equity Partners - The Malaysian Reserve

Mar 13, 2025
pulisher
Mar 13, 2025

Exosomes Drug Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne - openPR

Mar 13, 2025
pulisher
Mar 10, 2025

Exosomes Market Projected To Witness Substantial Growth, 2025-2032: Bio-Techne, QIAGEN, Lonza, Miltenyi - EIN News

Mar 10, 2025
pulisher
Mar 07, 2025

Creative Medical Technology secures $3.7 million through warrants By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 06, 2025

Where are the Opportunities in (CELZ) - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology secures $3.7 million through warrants - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross - EIN News

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Heritage Distilling Co. Announces Recent Achievements and Key Milestones for Salute Series Line of Premium Whiskeys - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements For Exercise Of Warrants For $3.7 Million Gross Proceeds - MENAFN.COM

Mar 06, 2025
pulisher
Mar 06, 2025

Can This $3.7M Cash Injection Fuel Creative Medical's Next Growth Phase? - StockTitan

Mar 06, 2025
pulisher
Mar 04, 2025

Head to Head Analysis: Cognition Therapeutics (NASDAQ:CGTX) versus Creative Medical Technology (NASDAQ:CELZ) - Defense World

Mar 04, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Sells 16,291 Shares of DNOW Inc. (NYSE:DNOW) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Sells 7,443 Shares of WisdomTree, Inc. (NYSE:WT) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Rhumbline Advisers - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Acquires 3,900 Shares of Vertex, Inc. (NASDAQ:VERX) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Cuts Position in American Assets Trust, Inc. (NYSE:AAT) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Purchases 3,454 Shares of Spirit AeroSystems Holdings, Inc. (NYSE:SPR) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Sells 314 Shares of S&T Bancorp, Inc. (NASDAQ:STBA) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Update - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Embecta Corp. (NASDAQ:EMBC) Shares Sold by Rhumbline Advisers - Defense World

Mar 01, 2025

Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):